Novel Biomarkers, ST‐Elevation Resolution, and Clinical Outcomes Following Primary Percutaneous Coronary Intervention

by Jay S. Shavadia, Christopher B. Granger, Wendimagegn Alemayehu, Cynthia M. Westerhout, Thomas J. Povsic, Sean Van Diepen, Christopher Defilippi, Paul W. Armstrong
Published 2020-07-01

Relationship Between Arterial Access and Outcomes in ST‐Elevation Myocardial Infarction With a Pharmacoinvasive Versus Primary Percutaneous Coronary Intervention Strategy: Insights...

by Jay Shavadia, Robert Welsh, Anthony Gershlick, Yinggan Zheng, Kurt Huber, Sigrun Halvorsen, Phillipe G. Steg, Frans Van de Werf, Paul W. Armstrong
Published 2016-06-01

Cardiovascular and Lifestyle Risk Factors and Cognitive Function in Patients With Stable Coronary Heart Disease

by Ralph A. H. Stewart, Claes Held, Sue Krug‐Gourley, Dawn Waterworth, Amanda Stebbins, Karen Chiswell, Emil Hagstrom, Paul W. Armstrong, Lars Wallentin, Harvey White
Published 2019-04-01

Providing Rapid Out of Hospital Acute Cardiovascular Treatment 4 (PROACT‐4)

by Justin A. Ezekowitz, Robert C. Welsh, Dale Weiss, Michael Chan, William Keeble, Fadi Khadour, Sanjay Sharma, Wayne Tymchak, Sunil Sookram, Neil Brass, Darren Knapp, Thomas L. Koshy, Yinggan Zheng, Paul W. Armstrong
Published 2015-12-01

Accelerometer vs. other activity measures in heart failure with preserved ejection fraction: the VITALITY‐HFpEF trial

by Javed Butler, Muhammad Shahzeb Khan, Tomasz Gasior, Tyler R. Erickson, Vanja Vlajnic, Frank Kramer, Robert O. Blaustein, David Goldsbury, Lothar Roessig, Carolyn S.P. Lam, Kevin J. Anstrom, Paul W. Armstrong, for the VITALITY Study Group
Published 2024-02-01

Blood Pressure and Safety Events With Vericiguat in the VICTORIA Trial

by Carolyn S. P. Lam, Hillary Mulder, Yuri Lopatin, Jose B. Vazquez‐Tanus, David Siu, Justin Ezekowitz, Burkert Pieske, Christopher M. O’Connor, Lothar Roessig, Mahesh J. Patel, Kevin J. Anstrom, Adrian F. Hernandez, Paul W. Armstrong
Published 2021-11-01

Relationship of Platelet Reactivity With Bleeding Outcomes During Long‐Term Treatment With Dual Antiplatelet Therapy for Medically Managed Patients With Non‐ST‐Segment Elevation Ac...

by Jan H. Cornel, E. Magnus Ohman, Benjamin Neely, Joseph A. Jakubowski, Deepak L. Bhatt, Harvey D. White, Diego Ardissino, Keith A.A. Fox, Dorairaj Prabhakaran, Paul W. Armstrong, David Erlinge, Udaya S. Tantry, Paul A. Gurbel, Matthew T. Roe
Published 2016-10-01

Efficacy and Safety of Vorapaxar in Non–ST‐Segment Elevation Acute Coronary Syndrome Patients Undergoing Noncardiac Surgery

by Sean vanDiepen, Pierluigi Tricoci, Mohua Podder, Cynthia M. Westerhout, Philip E. Aylward, Claes Held, Frans Van de Werf, John Strony, Lars Wallentin, David J. Moliterno, Harvey D. White, Kenneth W. Mahaffey, Robert A. Harrington, Paul W. Armstrong
Published 2015-12-01

Interaction of Body Mass Index on the Association Between N‐Terminal‐Pro‐b‐Type Natriuretic Peptide and Morbidity and Mortality in Patients With Acute Heart Failure: Findings From...

by Ankeet S. Bhatt, Lauren B. Cooper, Andrew P. Ambrosy, Robert M. Clare, Adrian Coles, Emer Joyce, Arun Krishnamoorthy, Javed Butler, G. Michael Felker, Justin A. Ezekowitz, Paul W. Armstrong, Adrian F. Hernandez, Christopher M. O'Connor, Robert J. Mentz
Published 2018-02-01

Stroke Outcomes With Vorapaxar Versus Placebo in Patients With Acute Coronary Syndromes: Insights From the TRACER Trial

by Leo Ungar, Robert M. Clare, Fatima Rodriguez, Bradley J. Kolls, Paul W. Armstrong, Philip Aylward, Claes Held, David J. Moliterno, John Strony, Frans Van de Werf, Lars Wallentin, Harvey D. White, Pierluigi Tricoci, Robert A. Harrington, Kenneth W. Mahaffey, Chiara Melloni
Published 2018-12-01

Self‐Reported Health and Outcomes in Patients With Stable Coronary Heart Disease

by Ralph A. H. Stewart, Emil Hagström, Claes Held, Tom Kai Ming Wang, Paul W. Armstrong, Philip E. Aylward, Christopher P. Cannon, Wolfgang Koenig, José Luis López‐Sendón, Emile R. Mohler, Nermin Hadziosmanovic, Susan Krug‐Gourley, Marco Antonio Ramos Corrales, Saulat Siddique, Philippe Gabriel Steg, Harvey D. White, Lars Wallentin
Published 2017-08-01

Prevalence of Cardiovascular Disease in a Population-Based Cohort of High-Cost Healthcare Services Users

by Padma Kaul, PhD, Nathan Klassen, MA, Douglas C. Dover, PhD, Nariman Sepehrvand, MD, PhD, Roopinder K. Sandhu, MD, Sean van Diepen, MD, MSc, Kevin Bainey, MD, M. Sean McMurtry, MD, PhD, Robert C. Welsh, MD, Justin A. Ezekowitz, MD, Shaun G. Goodman, MD, Paul W. Armstrong, MD, Finlay A. McAlister, MD
Published 2022-02-01

Lipoprotein‐Associated Phospholipase A2 Activity Is a Marker of Risk But Not a Useful Target for Treatment in Patients With Stable Coronary Heart Disease

by Lars Wallentin, Claes Held, Paul W. Armstrong, Christopher P. Cannon, Richard Y. Davies, Christopher B. Granger, Emil Hagström, Robert A. Harrington, Judith S. Hochman, Wolfgang Koenig, Sue Krug‐Gourley, Emile R. Mohler, Agneta Siegbahn, Elizabeth Tarka, Philippe Gabriel Steg, Ralph A. H. Stewart, Robert Weiss, Ollie Östlund, Harvey D. White, Andrzej Budaj, Diego Ardissino, Alvaro Avezum, Philip E. Aylward, Alfonso Bryce, Hong Chen, Ming‐Fong Chen, Ramon Corbalan, Anthony J. Dalby, Nicolas Danchin, Robbert J. De Winter, Stefan Denchev, Rafael Diaz, Moses Elisaf, Marcus D. Flather, Assen R. Goudev, Liliana Grinfeld, Steen Husted, Hyo‐Soo Kim, Ales Linhart, Eva Lonn, José López‐Sendón, Athanasios J. Manolis, José C. Nicolau, Prem Pais, Alexander Parkhomenko, Terje R. Pedersen, Daniel Pella, Marco A. Ramos‐Corrales, Mikhail Ruda, Mátyás Sereg, Saulat Siddique, Peter Sinnaeve, Piyamitr Sritara, Henk P. Swart, Rody G. Sy, Tamio Teramoto, Hung‐Fat Tse, W. Douglas Weaver, Margus Viigimaa, Dragos Vinereanu, Junren Zhu
Published 2016-06-01